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Abstract
To begin to understand the contributions of maternal obesity and over-nutrition to human development and the early
origins of obesity, we utilized a non-human primate model to investigate the effects of maternal high-fat feeding and
obesity on breast milk, maternal and fetal plasma fatty acid composition and fetal hepatic development. While the high-fat
diet (HFD) contained equivalent levels of n-3 fatty acids (FA’s) and higher levels of n-6 FA’s than the control diet (CTR), we
found significant decreases in docosahexaenoic acid (DHA) and total n-3 FA’s in HFD maternal and fetal plasma.
Furthermore, the HFD fetal plasma n-6:n-3 ratio was elevated and was significantly correlated to the maternal plasma n-6:
n-3 ratio and maternal hyperinsulinemia. Hepatic apoptosis was also increased in the HFD fetal liver. Switching HFD females to
a CTR diet duringa subsequentpregnancy normalizedfetal DHA, n-3 FA’s andfetal hepaticapoptosis to CTR levels. Breast milk
from HFD dams contained lower levels of eicosopentanoic acid (EPA) and DHA and lower levels of total protein than CTR
breast milk. This study links chronic maternal consumption of a HFD with fetal hepatic apoptosis and suggests that a
potentially pathological maternal fatty acid milieu is replicated in the developing fetal circulation in the nonhuman primate.
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Introduction
Over the last twenty years, obesity has dramatically increased in
the United States across every ethnic group studied [1,2]. Women of
childbearing age have not been spared from this upsurge, as nearly
50% of all women of childbearing age are either overweight or obese
and one-third have body mass indexes (BMI) of 30 or higher [3,4]. A
particularly concerning part of the emerging epidemic of obesity is
the increasing rise in the percentage of children and adolescents that
are either overweight or at risk for overweight [1,2,5]. In addition,
diseases once only found in adults are occurring with greater
frequency in pediatric populations. Type 2 diabetes mellitus as well
as secondary co-morbidities such as hypertension, non-alcoholic
fatty liver disease, hyperlipidemia, and metabolic syndrome are now
becoming increasingly common in children [6,7].
The increasing prevalence of metabolic diseases and obesity in
children is most often attributed to a combination of an energy
conserving, or ‘thrifty’ genotype, with a prevalent imbalance of
nutrient intake and expenditure in the developed world. An
emerging body of evidence also suggests that our ability to respond
to metabolic challenges during postnatal life is modified by
environmental influences during fetal development. Fetal devel-
opment is a critical period when exposure to environmental insults
in-utero has lifelong effects on the structure and function of organs,
tissues and body systems in the offspring.
There is strong evidence in humans that maternal nutrient
deprivation during pregnancy can program adipocyte metabolism
and fat mass towards a propensity for obesity, and lead to a wide
range of developmental effects in the offspring [8–15]. In addition,
maternal obesity and gestational diabetes mellitus (GDM) during
pregnancy has also been implicated in the development of
metabolic disorders in offspring, including macrosomia, impaired
glucose tolerance, and a higher risk of developing obesity and
diabetes as adults [16–25]. While epidemiological evidence has
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fetal growth and the programming of childhood weight, the
mechanisms underlying metabolic programming are poorly
understood, particularly in humans.
Rodent studies have demonstrated that a maternal high fat diet
during gestation and lactation, or overfeeding during the postnatal
period, alters the development of the pancreas and liver as well
as central and peripheral nervous systems involved in energy
homeostasis [26–40]. While extremely valuable, these rodent
studies do not address the fact that there are critical developmental
differences between rodents and primates, including both humans
and nonhuman primates (NHP). For example, the development of
important central circuits regulating appetite and metabolism
occurs prenatally in humans and NHP, while rodent maturation of
these systems primarily occurs postnatally [41–45]. Furthermore,
the macro- and micro-architecture of the placenta is markedly
different between rodents and humans, and this has important
implications for fetal nutrient transfer during development
(reviewed in [46]). Therefore, studies designed to provide
mechanistic links between the maternal gestational metabolic
environment and fetal metabolic programming, in support of
previous human epidemiological observations, requires animal
models that closely resemble human development.
To this end, we have utilized a unique non-human primate
model of maternal high fat/calorie diet-induced obesity (in the
absence of gestational diabetes) to address the impact that chronic
maternal consumption of a high-fat diet (HFD) may have on
metabolic programming [47]. We acknowledge that ‘high-fat’ is a
phrase that simplifies the complex nature of our dietary
intervention and therefore have supplied a detailed analysis of
the dietary constituents. Nonetheless, this model utilizes chronic
high fat feeding, and the level and composition of dietary fat are
not outside the norms for a modern western diet [48].
Our group has previously shown that a maternal HFD alters
fetal development and expression of hypothalamic neuropeptides
in the context of hypothalamic inflammation, as well as inducing
changes in the central serotonergic system [49,50]. In the liver,
HFD fetuses had premature gluconeogenic gene expression,
steatosis, elevated triglyceride content, and oxidative stress. In
addition, epigenetic changes and altered circadian gene expression
has been shown in the HFD fetal liver [51,52]. HFD fetal plasma
contained elevated levels of inflammatory cytokines, and elevated
triglycerides and glycerol that were highly correlated to maternal
levels. Other work with this model has shown that alterations in
serum metabolite profiles are present in HFD fetuses [53]. The
majority of these changes were observed irrespective of maternal
obesity or maternal insulin resistance status and persisted into the
early postnatal period. Importantly, switching HFD mothers to a
control diet during pregnancy alone (diet-reversal; REV) reversed
a number of the observed fetal hepatic pathologies towards control
levels [47,52].
In the present study, we further characterize our NHP model of
maternal HFD induced obesity [47], by a detailed analysis of fatty
acids in the diet, maternal plasma, breastmilk, and fetal plasma. In
addition, we extend previous findings by evaluating the effects that
a maternal HFD has on inflammation and apoptosis in the fetal
liver. Our results show that the experimental maternal HFD leads
to increased apoptosis in the developing fetal liver. In addition,
maternal and fetal HFD plasma have reduced levels of circulating
n-3 fatty acids when compared to CTR. Importantly, we
demonstrate that a maternal dietary intervention during pregnan-
cy (REV) normalized fetal hepatic apoptosis and returned plasma
n-3 fatty acids to CTR levels in dams and fetuses. These data
support the idea that the placenta does not protect the developing
fetus from a pro-inflammatory maternal lipid milieu. Because
these effects are associated with maternal diet during gestation and
lactation, and some are reversed with dietary manipulation limited
to these intervals, these data have critical public health
implications.
Materials and Methods
Macaque model of maternal overnutrition
All animal procedures have undergone an extensive review
process and were in accordance with the guidelines of Institutional
Animal Care and Use Committee of the Oregon National Primate
Research Center (ONPRC) and Oregon Health & Science
University. Protocols involved in this study were developed to
ameliorate suffering and have been approved under IACUC ID
number: IS00000224 (0622 for internal purposes). The Animal
Care and Use Program at the ONPRC abides by the Animal
Welfare Act and Regulations (CFR 9, Ch 1, Subchapter A)
enforced by the USDA, the Public Health Service Policy on
Humane Care and Use of Laboratory Animals, in accordance
with the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health, and the recommendations of the
Weatherall report; The Use of Non-human Primates in Research.
Japanese macaques matched for age (5–7 years at start) and
weight (7–9 Kg) were randomly assigned to two dietary groups in
the fall of 2002: 1: Control diet (CTR; 13% of calories from fat;
Monkey Diet no. 5052, Lab Diet, Richmond, IN, USA) or 2:
High-fat diet (HFD; 35.2% of calories from fat; Custom Diet
5A1F, Test Diet, Richmond, IN, USA). The HFD also included
calorically dense treats made with peanut butter. Both diets are
sufficient in vitamin, mineral, and protein content for normal
growth. Prior to this study, all animals were maintained on
standard monkey chow in large outdoor enclosures and were naive
to any experimental protocols.
Manufacturers specifications provided for both diets show that
the total metabolizable energy content of the CTR chow was
2.87 kcal/g and was apportioned at 26.8% energy from protein,
58.5% energy from carbohydrate, and 14.7% energy from fat.
The main source of fat in the CTR diet was soybean oil. The total
energy content of the maternal HFD chow was 4.2 kcal/g and was
apportioned at 16.7% energy from protein, 51.5% energy from
carbohydrate, and 31.8% energy from fat. The main sources of fat
in the HFD were lard, animal fat, butter and safflower oil.
The animals were group housed and had ad libitum access to
food and water. The group housing is important as it provides for
normal social behavior and exercise, which contribute to the
psychological well being of the animals and more closely resembles
the human condition. However, because the animals are group
housed it is not possible to determine individual food/calorie
intake. For maternal plasma studies, 11 CTR, 6 HFD, and 7 REV
dams were used.
Each maternal group was housed with two males so that
pregnancies would occur during the yearly breeding season
(November–February). The females were checked each successive
year for pregnancies starting in November by ultrasound, which
allows an estimate of gestational age 65 days. Twice a year the
animals underwent IV glucose tolerance tests (IVGTT) (Methods
S1a), once during the late summer (nonpregnant state) and once
during the early 3rd trimester of pregnancy. All of the above
procedures were done under ketamine sedation (5–10 mg/kg).
For our studies, ONPRC veterinarians terminated singleton
pregnancies from dams by cesarean section at gestational day 130
(G130), as determined by ultrasound. Pregnant dams were fasted
overnight for approximately 16 hours prior to surgical procedure.
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(100 mg/ml) at a dose of 10–15 mg/kg. Once animals were
sedated they were delivered to the surgical area and placed on
isoflurane gas; induced at 3%, then maintained at 1.0–1.5%.
Cesarean sections were performed by trained ONPRC veterinar-
ians and their staff, and occurred on scheduled days between 10:00
and 10:30 am.
Pre and post-operative care was maintained by the ONPRC
veterinary staff. Immediately prior to the cesarean section animals
received an intravenous dose of hydromorphone (0.5 mg if under
10 kg, 1.0 mg if over 10 kg). An additional intravenous dose of
hydromorphone was administered post-operatively, usually within
an hour after the start of the procedure. For the remainder of the
day following the cesarean section, intravenous hydromorphone
was given at 4:00 pm and again at 8:00 pm in combination with
buprenorphine (0.3 mg IM). The following day, hydromorphone
was administered at 8:00 am, 12:00 pm, 4:00 pm and then again
with buprenorphine at 8:00 pm. Animals remained in the surgical
ICU area for approximately 7 days under close veterinary
observation and were then released back into their group.
After cesarean section, fetuses were deeply anesthetized with
sodium pentobarbital (.30 mg/kg i.v.) and exsanguinated. All
peripheral tissues and brain were removed, weighed and stored for
subsequent protein and RNA extractions or for histological
analyses. All surgical procedures used in this study, were
performed each scheduled day in an identical manner, following
an a priori defined protocol in both technique and timing. Thus for
plasma analyses, blood draws were taken at approximately the
same time of day for dams and fetuses. Maternal blood was taken
during c-section from the femoral artery, and fetal blood samples
were taken from the abdominal aorta during necropsy.
Fetal studies were performed with 11 CTR, 7 HFD and 6 REV
animals. Normal full-term pregnancies for Japanese macaques is
175 days, thus G130 is in the early 3
rd trimester. G130 was chosen
after preliminary studies determined that this gestational age
represented a critical period for the development of several
metabolic systems: 1) hypothalamic circuits have started to
develop, 2) there is widespread pancreatic b-cell development, 3)
there is a full functioning placenta that is not at near term, and 4)
there is very little white adipose tissue (WAT).
Previous work with this model has demonstrated significant
increases in maternal leptin levels, decreases in maternal insulin
sensitivity, and increases in maternal weight gain starting with the
second year of maternal HFD exposure, and these changes persist
and become greater through year four [47]. For our fetal studies,
we are reporting differences in HFD fetuses whose mothers were
exposed to the maternal diet for at least four consecutive years. In
the fifth year of our studies, a diet-reversal protocol (REV) was
initiated to assess dietary impact independent of maternal obesity.
This protocol entailed switching a subgroup of adult females that
had been exposed to a high-fat diet for four consecutive years, to a
control diet 1–3 months before becoming pregnant and through-
out the pregnancy.
Maternal breast milk for fatty acid analysis was obtained at
postnatal day 30 (postnatal day 29.563 days, (mean 6 SD)) from 6
CTR and 16 HFD dams giving birth to full term infants. The
breast milk was collected during routine postnatal day 30 dual-
emission X-ray absorptiometry (DEXA) procedures for the
offspring. The DEXA procedure followed an a priori defined
protocol and breast milk was obtained at approximately the same
time of day for each animal. At 9:00 am, the mother was sedated
with ketamine (15 mg/kg) or telazol, if ketamine resistant. The
baby was separated from the mother for DEXA scanning. Two
hours later, 0.5 mL oxytocin was injected intravenously into the
mother to stimulate milk let down. The breast and nipple were
massaged and milk was collected into a 15 mL conical vial. The
milk sample was immediately stored on ice until centrifugation to
separate aqueous milk and cream layers.
Due to study design parameters in which the focus of the REV
group was on fetal effects, breast milk from the REV dams was not
available. In addition, during the two-year period that the breast
milk study encompassed, there were fewer pregnancies in CTR
dams (15) than in the HFD dams (23). The volume of milk
collected was highly variable and dependent on whether nursing
had occurred immediately prior to our procedures. Visual
inspection of the breast-milk was also used to identify and exclude
samples that were discolored or contaminated with maternal
blood. Thus, to obtain enough breast milk for the insulin, total
protein, leptin and cytokine assays we performed, and to provide
sufficient power for analysis, we sampled additional lactating CTR
Japanese macaque dams. Milking of these additional CTR dams
was performed during bi-annual colony health examinations and
included milk that was older than 30 days post-partum (post-natal
day 160634 (mean 6 SEM)). No differences were observed in the
CTR group between the older milk and the 30 days post-partum
milk for the insulin (12 CTR, 18 HFD dams) total protein (11
CTR, 8 HFD dams), leptin (20 CTR, 13 HFD dams) and cytokine
assays (14 CTR, 18 HFD dams), so they were grouped for analysis.
Detailed protocols for the insulin, total protein, leptin and cytokine
assays are described in Methods S1b.
Fatty acid profiles
The fatty acids present in each maternal diet, fasting maternal
plasmabreast milk and fetal plasma wereanalyzed bya modification
of the methods described by Langerstedt et al. [54]. Deuterated fatty
acids including d3C10:0, d3C14:0, d3C16:0, d3C18:0, d3C20:0 and
d4C22:0 were added to samples prior to extraction as internal
standards. Following hydrolysis and extraction, fatty acids were
derivatized to the pentafluorobenzyl (PFB)-esters. The fatty acid-
esters were analyzed by gas chromatography-mass spectroscopy
(GC-MS) on a Trace DSQ (Thermoelectron) operating in the
negative ion chemical ionization mode with methane as the reagent
gas.Thefattyacid-PFBesterswereseparatedonaDB-5 mscapillary
column(30 m60.25 mm60.25 mm)withheliumasthecarriergasat
a flow rate of 1 ml/min. Individual fatty acids were monitored with
selected ion monitoring and a dwell time of 50 ms for each ion
species. Each fatty acid was matched to the deuterated internal
standard closest in length and retention time. Peak area ratios of
known amounts of standard fatty acids and the internal standards
were used to generate calibration curves to quantify unknowns using
Xcalibur software.
Dynamic range and efficiency curves for Real-Time PCR
Macaque specific primer sets were evaluated to determine the
efficiency of our primer sets within a working range of cDNA
concentrations and identify an optimum concentration of cDNA
to use in Real-time PCR assays. A cDNA dilution series was made
from four random samples from each dietary group. The cDNA
was diluted based on initial RNA concentration and the
assumption of 100% reverse transcription efficiency. The dilution
series was designed so that each primer set started at an upper
limit of 50 ng total cDNA/reaction and decreased in 10 ng
increments to a minimum of 1 ng/reaction [55].
Primer validation Real-Time PCR reactions were run on an
Applied Biosystems 7300 as relative quantification plates with
SYBR master mix used at a 26 dilution. Following automatic
thresholding and standard baseline adjustments after each run, Ct
values were plotted as a function of the log (10) of the cDNA
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was calculated as 10‘(21/slope) and was used for our experimen-
tal quantification [55]. For experimental assays we chose a cDNA
concentration that gave us Ct threshold values across all dietary
groups of between 20 and 32 cycles. In cases where we could not
detect the target of interest in any diet group; threshold Ct values
.35, or SYBR fluorescence not rising above background at all, we
confirmed the presence of the target and the specificity of our
target primers on fetal spleen processed in an identical manner as
our liver samples. Additional protocols describing liver tissue RNA
extractions (Methods S1c) and primer design (Methods S1d)
are included as supporting information.
Real-Time PCR
Experimental Real-Time PCR reactions were run on an
Applied Biosystems 7300 as relative quantification plates. Target
and endogenous control primers were used at a final concentration
of 471 nM in a 21 ml reaction. SYBR master mix was used at the
manufacturer’s recommended 26 dilution. Dissociation curves
were produced for every well to monitor primer amplification of a
single target. Alg9 was used as an endogenous control for all our
experiments. The Alg9 primer set was designed by core facilities at
the Oregon National Regional Primate Center as an endogenous
control for macaque gene expression analysis, and subjected to
extensive gene stability validation in our model by use of the
geNorm VBA applet [57,58]. Primer sequences used for Real-
Time PCR are described in Table S1.
Relative quantification of target gene expression was calculated
across each dietary group using empirically derived efficiency
values for each primer set and calculating an efficiency-corrected
fold by the following formula:
Fold~(Etarget)
DCt(target control-target sample)=
(Eendo)
DCt(endo control-endo sample)
where E is the respective primer efficiency. The DCttarget was
calculated by choosing one calibrator sample from the control diet
group and subtracting subsequent target Ct values from that
calibrator across all groups. In addition, DCtendo was calculated by
using endogenous control Ct values for the same calibrator sample
as above, and subtracting subsequent endo Ct values from that
calibrator [55]. In situations where the optimum cDNA concen-
tration of our endogenous control differed from our target, we
produced cDNA dilutions for the endogenous control and target
from the same reverse-transcriptase reaction. Following the Real-
Time PCR reaction random target well reactions from each diet
group were run on a 2% agarose gel to verify amplicon singularity
and size. Bands of the expected size were excised, gel purified
(Qiaquick gel extraction kit, Qiagen #28706) and sequenced.
Target specificity was confirmed by BLAST and comparing
amplicon sequence with the NCBI macaque database.
TUNEL assay
We used an ApopTagH Peroxidase In-Situ TdT end-labeling
apoptosis detection kit (Chemicon S7100) on fetal CTR, HFD,
and REV paraffin embedded fetal liver sections (Right lobe,
5 microns thick) as per manufacturers instructions. Tissue was
deparaffinized in 3 washes of xylene, followed by graded alcohol
(100%, 95% and 70%) rehydration. Proteinase K (20 ug/ml)
digestion for 15 min at room temperature was followed by 2
washes in ddH2O. Endogenous peroxidases were quenched for
5 minutes in 3.0% hydrogen peroxide in 16 PBS. Following
application of proprietary equilibration buffer, the TdT enzyme
was incubated for one hour at 37uC. The TdT reaction was
stopped by immersion into wash buffer and the anti-digoxigenin
conjugate was applied and incubated at room temperature for
30 minutes. Following 4 washes in 16 PBS, the peroxidase
substrate was developed for 6 minutes at room temperature.
Samples were then washed in ddH2O and counterstained with
methyl green.
TUNEL imaging and quantification
Imaging was performed on a Marianas Digital Imaging
workstation equipped with a Zeiss Axiovert 200 M inverted
microscope (Zeiss Microimaging, Thornwood, NY) and a Cool-
snap camera (Roper Scientific, Tucson, AZ) by a blinded observer.
A montage of each liver section was created with the Marianas
Digital Imaging workstation using a 26 objective. Stereological
analysis of the 26montage was performed by masking the hepatic
area and placing 500 um6500 um regions with spacings of
1000 um61000 um and a random offset of 69.4 (x-coordinate)
and 513.4 (y-coordinate), on the image (SlideBook, Intelligent
Imaging Innovations, Denver, CO). Coordinates of each region
were recorded and then each region was imaged using a 106
objective. Following acquisition of between 20 to 40 106images
per section, masking was used to threshold and calculate the total
hepatic parenchyma area. An additional mask was used to
threshold TUNEL positive cells. Within the stereology program
we excluded TUNEL positive debris under 5 microns in width.
Following these adjustments, the number of TUNEL positive
stained cells (‘‘events’’) was automatically counted and the total
hepatic area was recorded. The number of events was converted to
a rate, defined as rate=(# events + 0.5)/ hepatic area, with the
overall rate for each animal being summarized as the median rate
among all animal-specific measurements. These rates were then
log transformed (base 10) for analysis, with the log transformation
aiding to stabilize variance and make the distribution of rates more
symmetric. (The addition of 0.5 in the initial rate calculation was
necessary to avoid taking the log of zero; among the 646
measurement only 7.6% were 0 counts). Analysis of variance
was then used to determine whether the median rate differed
according to diet.
Other analyses based on summarizing individual measurements
in terms of mean rate, as well as non-parametric analysis (Kruskal-
Wallis) applied to the current median-rate summary led to similar
conclusions and are not reported. Similarly, a linear mixed effect
model with count distributed according to a Poisson distribution
(and area treated as an offset) found similar conclusions to our
earlier and more simple approaches based on all summarizing
forms (median/mean) of the log transformed rates; consequently,
we present only results of the simpler analysis. All analyses
performed using R version 2.6.1 (R Development Core Team
(2007), R Foundation for Statistical Computing, Vienna, Austria.
ISBN 3-900051-07-0, URL: http://www.R-project.org.) Graphs
were produced with Prism software (GraphPad Software, Inc., La
Jolla, CA).
Data analysis
Data for all analyses not explicitly described above, were first
compiled and tested for normality by Shapiro-Wilk with STATA
(College Station, Texas) statistical software. Data were trans-
formed to fit Gaussian distributions and tested for significance by
ANOVA with a Bonferroni post-hoc analysis. Groups that did not
attain a Gaussian distribution by transformation were first tested
for overall significance by Kruskal-Wallis rank sum, followed by a
Wilcoxon rank sum test with a Bonferroni adjusted alpha to
determine significance between diet groups. Pair-wise analysis of
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offspring was performed using pairwise correlation in STATA. We
are reporting an overall Pearson correlation coefficient across our
three diet groups for each analysis. In addition, maternal and fetal
fatty acid samples were also tested by pairwise correlation in
STATA for an overall association with maternal insulin resistance
and glucose clearance. All graphs were made with Prism software
(GraphPad Software, Inc., La Jolla, CA).
Results
Maternal diet nutritional analysis
To initiate our analysis of the impact that maternal HFD has on
the developing NHP fetus, we chose to first examine differences in
fatty acid composition between the CTR and HFD diets. Using
gas chromatography-mass spectroscopy, we found that compared
to the CTR diet, the maternal HFD has higher levels of myristic
(C14:0), myristoleic (C14:1), palmitic (C16:0), palmitoleic (C16:1),
stearic (C18:0), oleic (C18:1, n-9), linoleic (LA, C18:2, n-6), a-
linolenic (ALA, C18:3, n-3), and arachidonic (AA, C20:4, n-6)
fatty acids. In addition, the HFD had lower levels of eicosopenta-
noic acid (EPA, C20:5, n-3) and docosahexaenoic acid (DHA,
C22:6, n-3) than the CTR diet. When fatty acid subtypes were
combined into groups, the HFD contained much higher levels of
total fatty acids, saturated, monounsaturated, polyunsaturated,
essential fatty acids (EFA, sum of C18:2 and C18:3) and total n-6
fatty acids (sum of C18:2 and C20:4) than in the CTR diet. Total
n-3 fatty acids (sum of C18:3, C20:5 and C22:6) were similar
between HFD and CTR maternal diets; however, a greater than
2-fold increase in HFD total n-6 fatty acids resulted in an n-6:n-3
ratio of 20:1 compared to the 9:1 n-6:n-3 ratio in the CTR diet
(Table 1). Thus, the HFD has an n-6:n-3 ratio that is reflective of
current trends in the Western diet [59].
Maternal plasma lipid profiles
Lipid analysis of maternal plasma total fatty acids revealed that
fasting levels of total fatty acids, total n-6, saturated, monounsat-
urated, polyunsaturated, and EFA’s were not significantly different
between the CTR, HFD and REV maternal diet groups (Table 2).
However, total n-3 fatty acids were significantly reduced in the
HFD group when compared to CTR and REV diet groups.
Comprising the reduction of total n-3 fatty acids were significant
decreases in EPA (n-3) and DHA (n-3) in the HFD group when
compared to both the CTR and REV dietary groups. There was
no change in DHA between CTR and REV; however, EPA was
higher in the REV group when compared to CTR. There were no
significant differences observed in a-linolenic acid (n-3) and
linoleic (n-6) across the three dietary groups. A trend was observed
for lower levels of arachidonic acid (n-6) in HFD maternal plasma,
but this did not reach statistical significance (p=0.06).
No significantchangeswereobservedintotalcirculating n-6fatty
acids between the three dietary groups. However, decreases in EPA
and DHA in the HFD group were large enough to significantly
lower total n-3 levels in maternal plasma. Consequently, the HFD
maternal plasma had a significantly higher n-6:n3 ratio (20:1) when
compared to CTR (5:1) or REV plasma (6:1).
Fetal plasma lipid profiles
Lipid analysis of fetal plasma also revealed that total fatty acids,
saturated, EFA’s and total n-6 fatty acid levels were not
significantly different between the CTR, HFD and REV diet
groups (Table 3). A significant increase in total polyunsaturated
fatty acids was found in the REV group when compared to the
HFD group but no statistical differences were observed when the
CTR group was compared to either the HFD or REV diet groups.
An increase in total monounsaturated fatty acids was observed in
the HFD fetal plasma compared to the CTR and REV groups.
The increase in monounsaturated fatty acids in the HFD group
was due to higher levels of the major monounsaturated, oleic acid
(C18:1, n-9), but the differences in oleic acid only reached
statistical significance when the HFD was compared to the REV
diet group.
As observed in the maternal circulation, total n-3 fatty acids
were significantly lower in the HFD group when compared to
CTR and REV. This decrease was due to significantly lower levels
of DHA in the HFD fetal plasma when compared to CTR and
REV. Again, due to the decreases in HFD circulating total n-3
fatty acids, a significant increase in the n-6:n-3 ratio was found
between CTR (4:1) and the HFD group (9:1). In the REV diet
group DHA and total n-3 fatty acids were normalized to CTR
levels. However, due to an increase in REV plasma n-6 fatty acids,
which was not itself significantly higher when compared to the
CTR and HFD diet groups, the REV n-6:n-3 ratio (7:1) was only
partially normalized to the CTR ratio. Thus, the reduced levels of
n-3 fatty acids and elevated n-6:n-3 fatty acid ratio found in the
HFD maternal plasma were also observed in the HFD fetal
plasma.
Plasma n-6:n-3 ratios are correlated between maternal
and fetal circulation
The fasting levels of total fatty acids, saturated, monounsatu-
rated and n-6 fatty acids are not different in the maternal plasma
Table 1. Gas chromatography- mass spectrometry analysis of
maternal chow.
1
DIET GROUP
Fatty
Acid
Common
Name (Type) CTR HFD
Mean SEM Mean SEM
HFD/CTR
Ratio
C 14:0 Myristic 0.5 0.1 15.0 1.3 30
C 14:1 Myristoleic 0.004 0.001 0.4 0.1 100
C 16:0 Palmitic 6.1 2.0 24.7 5.7 4.1
C 16:1 Palmitoleic 0.2 0.0 3.4 0.5 17
C 18:0 Stearic 2.9 1.0 20.2 1.9 7
C 18:1 Oleic (N9) 9.5 2.1 52.9 15.4 5.6
C 18:2 Linoleic (N6) 18.9 5.0 40.6 14.6 2.1
C 18:3 Linolenic (N3) 0.5 0.1 1.2 0.4 2.4
C 20:4 Arachidonic (N6) 0.04 0.02 0.4 0.1 10
C 20:5 EPA (N3) 0.8 0.2 0.3 0.1 0.4
C 22:6 DHA (N3) 1.0 0.5 0.6 0.2 0.6
Total Fatty Acids 40.3 4.8 169.6 39.4 4.2
Total Saturated 9.4 3.0 59.9 8.8 6.4
Total Monounsaturated 9.7 2.0 56.6 15.9 5.8
Total Polyunsaturated 21.2 5.8 52.6 20.5 2.5
Total Essential Fatty Acids 19.4 5.1 41.8 15.0 2.2
Total N6 19.0 5.0 50.2 19.7 2.2
Total N3 2.2 0.8 2.4 0.8 0.9
N6:N3 Ratio 8.8 1 19.9 0.9 2.3
1All values are mean 6 SEM and expressed as mg/g of dry chow.
doi:10.1371/journal.pone.0017261.t001
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in monounsaturated fatty acids, these findings are also observed in
fetal plasma. However, we observed significant decreases in DHA
and total n-3 fatty acids in both maternal and fetal HFD
circulation that were normalized with maternal diet reversal.
These findings suggest that circulating n-3 fatty acids, as essential
fatty acids, are dependent on dietary supply and availability in
both mother and fetus across our three dietary groups.
Our model provides us with the ability to perform pair-wise
analysis of circulating lipids between individual dams and their
offspring to investigate associations between maternal and fetal
parameters. Thus, we performed a pairwise correlation analysis
and found that there was a significant correlation (Figure 1A)
between the maternal n-6:n-3 ratio and the n-6:n-3 ratio found in
the fetus (Roverall=.63, p=.002). In addition, we found a weaker
but statistically significant association (Figure 1B) between
maternal EPA and fetal EPA (R=.43overall, p=.045). However,
we did not find a statistically significant association between
maternal and fetal plasma DHA.
Maternal obesity versus maternal consumption of a high-
fat diet
Previous work with this model has shown that following chronic
maternal consumption of a HFD two maternal phenotypes emerge
[47]. Compared to CTR animals, diet-sensitive HFD dams are
obese, hyperleptinemic, and insulin resistant. In contrast, the diet-
resistant HFD dams had normal insulin secretion during glucose
tolerance tests, similar body weights, body fat and circulating
leptin levels relative to the maternal CTR diet group even after
four years on the high-fat diet. To date, the majority of findings
regarding fetal development with this model have been indepen-
dent of maternal obesity and diabetes.
We tested whether maternal sensitivity to the HFD is associated
with either maternal or fetal fatty acid levels by pairwise
correlation. We found that the maternal insulin secretion (insulin
AUC) and maternal glucose clearance (glucose AUC), as
determined by third trimester maternal i.v. glucose tolerance
testing, were not correlated with fasting plasma levels of any
maternal fatty acids acquired at time of cesarean section (G130).
Interestingly, we found that the fetal plasma n-6:n-3 ratio was
positively correlated with maternal insulin AUC (Roverall=.61,
p=.002, Figure 2A). No other fetal plasma fatty acids assayed
were correlated with the maternal insulin AUC. Additionally, we
found that the total fetal plasma levels of saturated fatty acids
(Roverall=.54, p=.007, Figure 2B) were correlated with the
maternal glucose AUC, as were the individual saturated fatty acids
C14:0 (myristic acid; Roverall=.43, p=.04), C16:0 (palmitic acid;
Roverall=.45, p=.04). In addition, C18:1 (oleic acid; Roverall=.43,
p=.04) and C18:3 (a-linolenic acid ( n-3); Roverall=.50, p=.01 )
were also positively correlated with maternal glucose AUC
(Figure S1). These data extend previous associations found
between maternal diet sensitivity and fetal outcomes in our model
[53]. Our findings suggest that while maternal diet has been the
primary predictor of fetal outcomes thus far, other maternal
Table 2. Gas chromatography- mass spectrometry analysis of maternal plasma lipids.
1
DIET GROUP
Fatty Acid Common Name (Type) CTR HFD REV
Mean SEM Mean SEM Mean SEM p-value
2
C 14:0 Myristic 290.7 61.8 347.5 84.8 226.1 35.6 0.68
C 14:1 Myristoleic 4.7 1.0 3.3 0.4 4.7 0.9 0.52
C 16:0 Palmitic 2456.2 239.4 2187.7 209.8 2239.4 194.2 0.67
C 16:1 Palmitoleic 192.2 50.6 113.5 17.3 90.4 11.1 0.54
C 18:0 Stearic 796.7 60.1 1013.4 65.7 860.4 55.2 0.07
C 18:1 Oleic (N9) 828.7 129.0 1084.7 101.8 859.5 85.8 0.33
C 18:2 Linoleic (N6) 1167.9 150.6 1122.6 72.6 1395.6 231.8 0.73
C 18:3 Linolenic (N3) 27.8 4.0 28.6 2.1 31.3 4.5 0.81
C 20:4 Arachidonic (N6) 484.5 55.8 366.6 29.8 570.2 48.1 0.06
C 20:5 EPA (N3) 72.8
b,c 9.4 5.2
a,c 0.8 122.0
a,b 13.1 0.0001
C 22:6 DHA (N3) 219.4
b 33.8 39.8
a,c 2.4 177.5
b 21.2 0.0001
Total Fatty Acids 6541.5 632.3 6312.8 469.4 6377.7 568.6 0.9718
Total Saturated 3543.6 310.6 3548.6 310.8 3325.9 264.7 0.89
Total Monounsaturated 1025.5 170.5 1201.4 117.6 954.6 90.7 0.58
Total Polyunsaturated 1972.5 238.6 1562.8 81.8 2270.2 308.0 0.33
Total Essential Fatty Acids 1195.7 154.5 1151.2 74.7 1426.5 237.1 0.61
Total N6 1652.5 203.0 1489.2 80.3 1951.5 280.1 0.53
Total N3 320
b 37.4 73.7
a,c 2.7 330.8
b 30.2 0.0001
N6:N3 Ratio 5.2
b 0.2 20.2
a,c 0.9 6.1
b 0.5 0.0009
1All values are means 6 SEM and are expressed as mmol/L. (n=11 for CTR, n=6 for HFD, n=6 for REV).
2Overall significance as determined by ANOVA or Kruskal-Wallis rank sum test.
aSignificantly different from CTR, p,.0167, Bonferroni adjusted a.
bSignificantly different from HFD, p,.0167, Bonferroni adjusted a.
cSignificantly different from REV, p,.0167, Bonferroni adjusted a.
doi:10.1371/journal.pone.0017261.t002
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important roles in determining the fatty acid milieu of the
developing fetus.
Inflammation in the high-fat fetal liver
Recent work with this model suggested that non-alcoholic fatty
liver disease (NAFLD) is present in the HFD fetal liver. McCurdy
et al. demonstrated that oxidative damage, hepatic steatosis, and
upregulation of phospho-JNK1 that was highly correlated with
levels of fetal liver triglycerides were present in the HFD fetal livers
[47]. To extend these findings, we investigated whether inflam-
mation and consequent evidence of non-alcoholic steato-hepatitis
(NASH) was present in the HFD fetal liver. We used Real-time
PCR to evaluate the expression of inflammatory markers between
CTR, HFD and REV fetal livers (Table 4). We found that the
expression of interleukin-10 (IL-10) was significantly different
across the three dietary groups and lower in the REV group, but
post hoc tests did not show statistical significance when compared
to the CTR and HFD diet groups. Unexpectedly, the expression of
Arginase-1 in the REV diet group, a marker of Th2 macrophage
activation [60,61], was significantly decreased when compared to
the CTR and HFD groups. No differences were observed in the
expression of any of the other inflammatory markers we assayed
between the CTR, HFD and REV maternal diet groups. These
data suggest that the fetal liver is not the origin of the increased
levels of pro-inflammatory cytokines found in fetal circulation in
previous work with this model [47].
Apoptosis in high-fat fetal liver
During gestation the fetal liver directly receives about 50% of
maternal blood flow via the branch of the umbilical vein that
connects to the portal vein [62]. Thus, the fetal liver, and
particularly the right lobe of the fetal liver, is anatomically
positioned to be directly affected by factors that are present in the
umbilical circulation. Given the increases in pro-inflammatory
cytokines found in the fetal umbilical circulation and the evidence
of NAFLD reported in previous work [47], we performed a
TUNEL assay to examine whether evidence of increased hepatic
apoptosis was present in fetal livers exposed to a maternal HFD.
We found that there is a significant increase in the number of
apoptotic cells in the HFD fetal liver compared to CTR when
normalized to hepatic area (2.14 fold increase, p,.05). Impor-
tantly, by switching a subgroup of HFD mothers to a control diet
during a subsequent pregnancy (REV), apoptosis in the fetal liver
was completely normalized to baseline (Figure 3).
Postnatal Studies
To begin to understand the long-term metabolic programming
effects that a maternal high-fat diet has on the offspring, it is
necessary to separate effects that occur in-utero from changes that
occur after parturition. Lactation is a critical period of develop-
ment for the offspring that may be sensitive to maternal obesity
and consumption of a high-fat diet. To begin to address the effects
that maternal obesity and overnutrition may have during lactation,
we performed gas chromatograph mass spectroscopy on maternal
Table 3. Gas chromatography- mass spectrometry analysis of fetal plasma lipids.
1
DIET GROUP
Fatty Acid Common Name (Type) CTR HFD REV
Mean SEM Mean SEM Mean SEM p-value
2
C 14:0 Myristic 125.1 18.2 164.0 34.5 127.2 32.9 0.57
C 14:1 Myristoleic 4.4 1.0 6.3 1.9 5.5 1.9 0.8
C 16:0 Palmitic 708.3 108.3 647.5 98.4 737.4 146.3 0.88
C 16:1 Palmitoleic 146.1 19.7 118.8 10.7 115.2 15.6 0.49
C 18:0 Stearic 455.0 37.7 419.1 63.9 385.7 22.3 0.6
C 18:1 Oleic (N9) 473.2 56.5 724.7
c 73.9 390.2
b 103.1 0.02
C 18:2 Linoleic (N6) 498.6 73.0 450.0 31.9 976.9 293.5 0.17
C 18:3 Linolenic (N3) 13.9 1.8 13.7 1.5 14.2 1.9 0.98
C 20:4 Arachidonic (N6) 572.6 152.4 417.3 111.7 675.6 229.3 0.4
C 20:5 EPA (N3) 42.6 9.1 30.9 5.4 67.9 20.3 0.29
C 22:6 DHA (N3) 273.9
b 78.7 52.2
a 6.0 259.4 119.3 0.01
Total Fatty Acids 3313.7 404.9 3044.4 243.2 3755.1 566.3 0.65
Total Saturated 1288.4 134.8 1230.5 175.4 1250.2 164.9 0.96
Total Monounsaturated 623.7 70.5 849.8 82.1 510.8 111.7 0.05
Total Polyunsaturated 1401.7 279.8 964.1
c 118.7 1994.0
b 372.4 0.047
Total Essential Fatty Acids 512.5 74.8 463.7 32.4 991.1 294.3 0.19
Total N6 1071.2 201.1 867.3 114.1 1652.5 310.9 0.09
Total N3 330.5
b 80.1 96.8
a,c 6.8 341.5
b 110.1 0.001
N6:N3 Ratio 3.6
b 0.2 8.9
a 0.9 6.7 1.7 0.007
1All values are means 6 SEM and are expressed as mmol/L. (n=11 for CTR, n=7 for HFD, n=6 for REV).
2Overall significance as determined by ANOVA or Kruskal-Wallis rank sum test.
aSignificantly different from CTR, p,.0167, Bonferroni adjusted a.
bSignificantly different from HFD, p,.0167, Bonferroni adjusted a.
cSignificantly different from REV, p,.0167, Bonferroni adjusted a.
doi:10.1371/journal.pone.0017261.t003
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maternal fatty acids. In addition, we assayed levels of insulin, total
protein, and leptin as well as interleukin-1b present in maternal
breast milk.
Maternal breast milk lipid profiles
In the breast milk we found no changes in total fatty acids in the
HFD group versus CTR. C14:0 (myristic), C16:0 (palmitic), C18:0
(stearic) and total saturated fatty acids were not higher in the HFD
group when compared to control (Table 5). There were no
differences in total levels of monounsaturated fatty acids as well as
C16:1 (palmitoleic) and C18:1 (oleic). Total polyunsaturated fatty
acids were unchanged in HFD breast milk when compared to
CTR. Total n-6 fatty acids, as well as C18:2 (linoleic) and C20:4
(arachidonic), were unchanged in the HFD breast milk when
compared to CTR. Total n-3 fatty acids were also unchanged
between the CTR and HFD diet groups. However, C20:5 (EPA,
n-3) and C22:6 (DHA, n-3) were significantly lower in the HFD
breast milk when compared to CTR breast milk. C18:3 (linolenic,
n-3) was the largest component of total n-3 fatty acids assayed and
was unchanged between the CTR and HFD diet groups. Thus,
the observed decreases in EPA and DHA were not large enough to
significantly lower the total levels of breast milk n-3 fatty acids.
The mean n-6:n-3 ratio was higher in the HFD (19:1) breast milk
than CTR breast milk (9:1). However, a large variance in both
groups prevented the increased HFD n-6:n-3 ratio from attaining
significance. Overall, the significant decreases in EPA and DHA in
HFD breast milk reflect what was also observed in maternal and
fetal plasma.
To further characterize the effects that maternal HFD had on
breast milk, we performed radio-immunoassays for insulin and
leptin. We found that insulin levels in maternal breast milk are
significantly higher (2-fold) in HFD mothers versus CTR
(Figure 4A). We found no changes in the levels of leptin in
maternal breast milk between CTR and HFD, although the levels
were quite low in both groups (data not shown). We also found no
differences in the levels of the inflammatory cytokine IL-1b
Figure 1. Correlation of fetal plasma fatty acids with maternal
plasma fatty acids. Pair-wise correlation analysis of the plasma N6:N3
fatty acid ratio (A), and plasma EPA levels (B), between CTR, HFD and
REV Japanese macaque dams and their respective third trimester
fetuses (n=22 maternal/fetal pairs). Both the plasma N6:N3 FA ratio and
plasma EPA levels are correlated between maternal and fetal circulation.
(CTR: white squares, HFD: dark grey circles, REV: grey diamonds).
doi:10.1371/journal.pone.0017261.g001
Figure 2. Correlation of fetal plasma fatty acids with maternal
insulin resistance and glucose clearance. Pair-wise correlation
analysis of fetal plasma N6:N3 fatty acid ratio with respective maternal
insulin AUC (A), across CTR, HFD and REV maternal diet groups. Pair-
wise correlation analysis of total fetal plasma saturated FA’s with
respective maternal glucose AUC (B), across CTR, HFD and REV maternal
diet groups. (n=23 maternal/fetal pairs). Fetal N6:N3 ratio is positively
correlated with maternal insulin AUC. Total fetal plasma saturated FA’s
are correlated with maternal glucose AUC. (CTR: white squares, HFD:
dark grey circles, REV: grey diamonds).
doi:10.1371/journal.pone.0017261.g002
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protein levels in HFD breast milk are significantly lower than in
the CTR breast milk (Figure 4B).
Postnatal phenotype
Given the proinflammatory environment our cohort of HFD
animals were exposed to in-utero, combined with increased
apoptosis in the fetal liver and the significant changes in breast
milk composition, we examined the offspring from CTR and HFD
dams to determine if phenotype differences were apparent in the
postnatal period. Previous work with this model demonstrated that
the offspring of HFD dams had similar bodyweights at postnatal
day 30 (P30) and post-natal day 90 (P90) as CTR offspring, and
higher levels of body-fat at P90 [47]. The current results again
showed that body weights were similar between the CTR and
HFD offspring at the P30 and P90 time points (Figure 5A) and
that the HFD offspring had higher body fat at P90 than CTR
offspring, as determined by DEXA scanning (Figure 5B). In
addition, HFD offspring had significantly lower lean body mass
than CTR offspring at P90 (figure 5C). We measured bone
mineral content as well and found no differences at either P30 or
P90 offspring between the two diet groups (Figure 5D). Thus,
while total body weights are similar at P90 between CTR and
HFD offspring, the HFD offspring have higher body fat and lower
lean body mass than CTR offspring.
Discussion
While much work has been done in the NHP to highlight the
effects that maternal nutrient deprivation has on development of
metabolic systems in the offspring [63–67], there is a fundamental
gap in understanding the contributions that maternal obesity and
maternal nutrient excess provide to metabolic programming.
Previous work with this model has demonstrated that a maternal
HFD altered fetal development and expression of key hypotha-
lamic neuropeptides in the context of hypothalamic inflammation
[49]. Furthermore, HFD fetal plasma contained elevated levels of
inflammatory cytokines, and elevated triglycerides and glycerol
that were highly correlated with maternal levels. In the liver, HFD
fetuses had premature gluconeogenic gene expression, steatosis,
elevated triglyceride content, and oxidative stress. The majority of
these changes were observed irrespective of maternal obesity or
maternal insulin resistance status and persisted into the early
postnatal period. Importantly, switching HFD mothers to a
control diet during pregnancy alone (diet-reversal; REV) normal-
ized a number of the observed fetal hepatic pathologies towards
control levels [47].
In the present study, we report in the nonhuman primate that
chronic maternal HFD consumption, independent of maternal
obesity or diabetes, leads to significantly reduced plasma levels of
n-3 fatty acids in fasted HFD pregnant dams and third trimester
fetuses. Our dietary model was designed to mimic the typical
Western diet being consumed by a majority of pregnant women in
the developed world. Whether the pathology is induced by
elevated dietary fat content per se or is instead due to a change in
dietary fatty acid composition (e.g. elevated n-6:n-3 ratio) was not
addressed by this experimental design. Furthermore, we cannot
draw conclusions regarding whether specific fatty acid manipula-
Table 4. Inflammatory marker mRNA expression in fetal
liver.
1
DIET GROUP
Target CTR HFD REV
p-
value2
Mean SEM Mean SEM Mean SEM
Interferon-c 0.42 0.11 0.38 0.11 0.32 0.06 0.87
Interleukin-1b 0.95 0.26 1.05 0.24 0.89 0.11 0.82
Interleukin-4 undetected undetected undetected n/a
Interleukin-6 undetected undetected undetected n/a
Interleukin-10 0.97 0.06 1.19 0.18 0.69 0.11 0.045
I-TAC (CXCL11) 0.93 0.12 1.06 0.08 0.82 0.15 0.1
Lymphotoxin-a 0.76 0.11 0.79 0.08 0.77 0.05 0.59
MCP-1 (CCL2) 0.78 0.1 0.81 0.14 0.75 0.06 0.91
Tumor Necrosis Factor-a 0.82 0.16 0.71 0.07 0.53 0.08 0.28
Arginase-1 1.01 0.09 1.00 0.07 65
a,b 0.04 0.009
C-Reactive protein 1.93 0.32 1.48 0.22 2.19 0.41 0.11
1All values are means 6 SEM and are expressed as relative fold to CTR calibrator
sample. (n=7 for CTR, n=8 for HFD, n=7 for REV).
2Overall significance as determined by Kruskal-Wallis rank sum test.
aSignificantly different from CTR, p,.0167, Bonferroni adjusted a.
bSignificantly different from HFD, p,.0167, Bonferroni adjusted a.
cSignificantly different from REV, p,.0167, Bonferroni adjusted a.
doi:10.1371/journal.pone.0017261.t004
Figure 3. Fetal hepatic apoptosis. Quantification of TUNEL positive
cells normalized to hepatic parenchyma area in G130 macaque fetal
liver for CTR, HFD, and REV maternal diet groups (A). Data are expressed
as fold increase over CTR of the median rate 6 standard error (CTR;
n=6, HFD; n=7, REV; n=6,
*P,.05 versus CTR, ANOVA). Representative
brightfield images for TUNEL staining in CTR (B) and HFD (C) G130 fetal
liver. TUNEL staining was returned to CTR levels following maternal diet
reversal (REV), thus representative REV image is not pictured. Scale bar,
50mm.
doi:10.1371/journal.pone.0017261.g003
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the developing fetus.
In HFD dams we observed significantly reduced fasting plasma
levels of DHA, EPA and total n-3 fatty acids. In the HFD fetal
circulation, plasma levels of DHA and total n-3 fatty acids were
also significantly reduced when compared to the CTR diet
animals. HFD breast milk contained lower levels of EPA and
DHA than CTR breast milk, however total n-3 fatty acids were
not different between CTR and HFD breast milk. We also
observed that apoptosis was significantly increased in the HFD
fetal liver. Importantly, we found that returning HFD dams to a
CTR diet during pregnancy normalized plasma n-3 fatty acids in
pregnant dams and fetuses and returned fetal hepatic apoptosis to
control levels.
The maternal HFD diet had by definition a much higher total
fat content than the CTR diet including much higher levels of
saturated, monounsaturated and polyunsaturated fats. Among the
essential fatty acids, the HFD also contained slightly higher levels
of linolenic acid (C18:3 n–3) but double the levels of the more
abundant linoleic acid (C18:2 n–6) and total n-6 fatty acids.
Consequently the HFD chow n-6:n-3 ratio was 2-fold higher than
the CTR n-6:n-3 ratio. The high saturated and monounsaturated
fatty acids in the HFD reflect that its fat largely came from animal
sources (lard, animal fat, and butter), versus the CTR diet (grains
and soybean oil). Also included in the maternal HFD were daily
calorie-dense treats made from peanut butter.
In humans, a recent report showed that low-nutrient-density
foods, consisting of refined carbohydrates and animal products
high in saturated fat, were the major contributors to the total
energy intake for a cohort of pregnant women [68]. While this
study was small in scope, the consumption of a diet that is high in
calories and saturated fats is similar to findings from nationally
representative studies of children and non-pregnant women
[69,70]. Thus, our NHP HFD has strikingly similar characteristics
to what is known about human dietary choices during pregnancy.
The present data are particularly relevant in light of the fact that
o v e rt h el a s t1 0 0y e a r sd i e t a r yn - 6 : n - 3r a t i o sh a v eg o n ef r o mb e i n g
close to 1:1 to approximately 20:1 [71]. There is strong evidence
suggesting that cellular membrane long chain polyunsaturated fatty
acid composition is largely determined by dietary ratios [72]. Thus,
the maternal and fetal plasma n-6:n-3 ratio mirrored the n-6:n-3
Table 5. Gas chromatography- mass spectrometry analysis of
maternal breast milk lipids.
1
DIET GROUP
Fatty
Acid
Common
Name (Type) CTR HFD p-value2
Mean SEM Mean SEM
C 14:0 Myristic 25.8 16.1 49.8 12.4 0.18
C 14:1 Myristoleic 24.6 11.3 33.7 11.7 0.51
C 16:0 Palmitic 60.1 18.7 87.7 13.3 0.42
C 16:1 Palmitoleic 64.0 24.0 52.4 17.1 0.42
C 18:0 Stearic 27.9 8.3 46.4 6.8 0.10
C 18:1 Oleic (N9) 43.2 23.7 67.5 15.5 0.18
C 18:2 Linoleic (N6) 64.6 21.5 56.1 5.5 0.51
C 18:3 Linolenic (N3) 13.2 5.0 15.4 5.3 0.61
C 20:4 Arachidonic (N6) 1.7 0.5 1.9 0.3 0.48
C 20:5 EPA (N3) 0.6 0.2 0.2 0.1 0.012
C 22:6 DHA (N3) 2.3 0.6 0.3 0.0 0.0007
Total Fatty Acids 328.1 61.5 411.6 32.5 0.30
Total Saturated 113.9 41.2 183.9 29.9 0.21
Total Monounsaturated 131.8 24.1 153.7 18.6 0.61
Total Polyunsaturated 82.4 20.2 74.0 7.0 0.71
Total Essential Fatty Acids 77.8 19.0 71.5 6.7 0.71
Total N6 66.3 21.9 58.0 5.7 0.51
Total N3 16.1 4.9 16.0 5.4 0.51
N6:N3 Ratio 9.1 3.6 18.9 3.5 0.16
1All values are means 6 SEM and are expressed as mmol/L. (n=6 for CTR, n=16
for HFD).
2Overall significance as determined by Student’s T-test or Wilcoxon rank sum
test.
doi:10.1371/journal.pone.0017261.t005
Figure 4. Maternal breast milk insulin and protein. Analysis of
insulin (A) and total protein levels (B) in breast milk from macaque dams
in CTR (white bars) and HFD (black bars) maternal diet groups. A. Insulin
was assayed by a commercially available primate RIA kit. HFD dams
have significantly higher levels of insulin in their breast milk than CTR
dams ( CTR; n=11, HFD; n=17,
**P,.01 versus CTR, Wilcoxon rank sum
test). B. Macaque breast milk total protein levels were measured from
the aqueous layer using a BCA
TM Protein Assay kit across CTR (white
bars) and HFD (black bars) maternal diet groups. HFD breast milk
contains significantly lower levels of total protein when compared to
CTR ( CTR; n=13, HFD; n=17,
*P,.05 versus CTR, Student’s t-test).
doi:10.1371/journal.pone.0017261.g004
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inthe HFD chow was a resultofincreases inn-6 fatty acids. Notably,
the maternal and fetal HFD plasma n-6:n-3 ratio was driven by
significant decreases in n-3 fatty acids when compared to CTR
plasma. In particular, DHA was significantly decreased in both the
maternal and fetal HFD circulation. Furthermore, significant
decreases in EPA and DHA were observed in breast milk. Thus,
the HFD offspring are provided with decreased levels of EPA, DHA
and n-3 fatty acids during both fetal and early postnatal life,
developmental periods that are dependent solely on maternal
transfer of nutritional substrates for normal growth.
The n-3 and n-6 long chain polyunsaturated fatty acids,
particularly DHA and AA, are critical for proper infant growth
and neurodevelopment (reviewed in [73]). DHA and AA are both
highly enriched in neural tissue while DHA is the major
component of retinal photoreceptor membranes [74–76]. While
only non-esterified fatty acids (NEFA) can be transferred from
mother to fetus directly, other mechanisms, including hydrolysis of
triglycerides and receptor mediated transfer, allow fatty acids
including docosahexaenoic acid (DHA, 22:6 n-3), eicosapentae-
noic acid (EPA, 20:5 n-3) and arachidonic acid (AA, 20:4 n-6), to
be transferred through the placenta to the fetus [77–81].
In thehuman fetus,thereis limitedcapacityfor denovolipogenesis
and the precursors for fetal fat accretion are primarily supplied
trans-placentally and consist of maternal substrates derived from
lipids rather than from glucose [81–83]. It has also been shown in
baboons that while the fetus has the capacity to synthesize DHA
from its EFA precursor, a-linolenic acid, preformed maternal DHA
is preferentially used for DHA accretion in the fetal brain [84–86].
Thus, the composition of the fatty acid supply to the fetus is mainly
determined by maternal lipid profile and suggests that modifica-
tions of maternal diet or metabolic homeostasis will affect delivery
of lipid substrates to the fetus [87,88]. Our results support these
findings and demonstrate that decreased circulating levels of DHA,
total n-3 fatty acids, and an elevated n-6:n-3 ratio was recapitulated
in both maternal and fetal circulation.
Previous work in nonhuman primates demonstrated that dietary
deprivation of n-3 fatty acids, and consequent decreases in plasma
n-3 fatty acids during the prenatal and postnatal periods, had
profound effects on brain and visual system fatty acid composition
and retinal function of fetuses and infants [89,90]. Decreased levels
of n-3 fatty acids during development have also been associated
with altered acetylcholine and dopamine release in rodents
[91,92]. Recently it was reported in our model, that fetuses
exposed to a maternal HFD displayed significant changes in
central serotonergic systems and nearly 78% of the HFD offspring
displayed increased anxious or aggressive behavior during
behavioral tests at postnatal day 130 [50]. Our work demonstrates
that circulating levels of DHA and total n-3 fatty acids are
significantly reduced in the HFD maternal and fetal plasma. Thus
while the changes in fetal brain development previously reported
in our model are likely to be multifactorial, our data suggests that
Figure 5. Offspring body composition. DEXA analysis of macaque offspring at post-natal day 30 (P30) and post-natal day 90 (P90) from CTR
(white bars) and HFD (black bars) diet groups. A. Total weight of macaque offspring at P30 and P90. B. Normalized fat mass of macaque offspring
between CTR and HFD diet groups at P30 and P90 (
*P,.05 versus CTR, Student’s t-test). C. Normalized lean body mass (LBM) of macaque offspring
between CTR and HFD diet groups at P30 and P90 (
*P,.05 versus CTR, Student’s t-test). D. Normalized bone mineral content (BMC) of macaque
offspring between CTR and HFD diet groups at P30 and P90. All data is expressed as mean 6 standard error (P30 CTR; n=15, P30 HFD; n=17, P90
CTR; n=13, P90 HFD; n=19).
doi:10.1371/journal.pone.0017261.g005
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HFD fetal circulation may be partly responsible.
While the maternal HFD chow has decreased levels of EPA and
DHA when compared to the CTR chow, the levels of total n-3
fatty acids were not different between two diets. In addition, the
maternal HFD has much higher levels of a-linolenic acid (C18:3,
n-3), an essential fatty acid precursor necessary for DHA synthesis,
than the CTR chow. Neuringer et al. [90] demonstrated in the
NHP that plasma levels of DHA could be maintained in pregnant
dams fed a diet containing 8% a-linolenic acid despite
undetectable levels of pre-formed DHA. It has been well
established that the desaturases responsible for synthesis of DHA
from a-linolenic acid are subject to regulation from dietary and
hormonal factors [93–98]; in particular, n–3 and n–6 fatty acids
compete as substrates for these desaturases as well as for uptake
into tissues. Thus it is reasonable to conclude that the decreased
levels of maternal plasma DHA and total n-3 fatty acids we
observed are due to the high n–6:n–3 ratio of the HFD.
The present study expands upon previous findings that suggest
that maternal diet can lead to severe inflammatory and oxidative
stress in the fetal liver. McCurdy et al. explored the effects of
maternal HFD in this model and demonstrated evidence of fetal
hepatic steatosis, oxidative stress, upregulation of heat-shock
proteins, and increased phosphorylation of c-Jun NH2-terminal
kinase (p-JNK), and increased inflammatory cytokines in the fetal
circulation [47]. While our data does not show that the HFD fetal
liver is the primary site of cytokine synthesis (at least at a
transcriptional level), the circulating inflammatory insult to the
developing fetal liver in our model is nonetheless quite significant.
Hepatocyte apoptosis is a marker of disease severity in numerous
hepatic disease states [99–101]. In fact, the severity of hepatocyte
apoptosis is significantly correlated with histopathological and
biochemical markers of NASH and hepatic fibrosis [102]. There is
evidence that there are connections between fatty acids, hepatic
steatosis and hepatic apoptosis. For example, incubation of HepG2
cells in-vitro with saturated and monounsaturated fatty acids
produced steatosis and p-JNK-dependent apoptosis that was more
pronounced with saturated fatty acids [103]. In primary rat
hepatocytes, treatment with oleic and stearic acid induced steatosis
and sensitized hepatocytes to cytotoxicity mediated by tumor
necrosis factor related apoptosis inducing ligand (TRAIL) [104].
Ourdatashowasignificantincreaseinthenumbersofapoptoticcells
in fetal livers exposed to a maternal high-fat diet. Previous findings of
severe hepatic steatosis, increases in p-JNK, and high circulating
levels of inflammatory cytokines [47], as well as our current findings
of increased oleic acid in the fetal circulation are consistent with
previously described mechanisms of hepatic apoptosis. To our
knowledge, the increased apoptosis in the HFD fetal liver is a novel
finding that reinforces the extent of damage occurring within the
developing fetal liver. However, the regenerative capacity of the liver
is formidable and studies already in progress will determine whether
permanent hepatic damage is evident in these animals.
Our NHP model is a sophisticated and effective tool that makes it
possible to quickly translate our findings into human clinical
research studies. In addition to our findings, previous work with this
model highlights the complex relationship between maternal diet
and obesity. It has been shown that fetal serum metabolites are
reduced under maternal high fat diet conditions. In agreement with
our fatty acid findings, changes in specific fetal serum metabolites
were associated with maternal diet, while others were associated
with maternal obesity and insulin resistance [53]. Future studies are
needed to untangle the contribution of maternal phenotype from
maternal diet and their combined effects on fetal development
beforecomprehensive interventionsareemployed. Withinthe midst
of the present childhood obesity epidemic, it is critical that we move
our findings forward into human studies and potentially into the
realm of public health policy and clinical practice.
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